The rise in NRF2 expression can also be elicited at the epigenetic level; for example, hypermethylation of the first five CpG sites in the NRF2 promoter was associated with mouse prostate tumorigenesis [12] and the frequency of demethylation was significantly higher in colorectal cancer [13]. This evidence concerns the gene NFE2L2 and colorectal cancer.